Trial Profile
A Phase II Study of Epacadostat and Pembrolizumab in Patients With Imatinib Refractory Advanced Gastrointestinal Stromal Tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Epacadostat (Primary) ; Pembrolizumab (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 18 Mar 2021 Status changed from active, no longer recruiting to completed.
- 16 Dec 2019 Planned End Date changed from 1 Sep 2019 to 1 Dec 2021.
- 13 Dec 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Dec 2021.